Related references
Note: Only part of the references are listed.Cell cycle on the crossroad of tumorigenesis and cancer therapy
Jing Liu et al.
TRENDS IN CELL BIOLOGY (2022)
Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma
Shuangshuang Yin et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Role of Sciellin in gallbladder cancer proliferation and formation of neutrophil extracellular traps
Yang Li et al.
CELL DEATH & DISEASE (2021)
Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors
Xiaojing Lu et al.
CANCER RESEARCH (2021)
Molecular mechanisms of APC/C release from spindle assembly checkpoint inhibition by APC/C SUMOylation
Stanislau Yatskevich et al.
CELL REPORTS (2021)
Bub1 kinase in the regulation of mitosis
Taekyung Kim et al.
ANIMAL CELLS AND SYSTEMS (2021)
Cyclin A triggers Mitosis either via the Greatwall kinase pathway or Cyclin B
Nadia Hegarat et al.
EMBO JOURNAL (2020)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neutrophils escort circulating tumour cells to enable cell cycle progression
Barbara Maria Szczerba et al.
NATURE (2019)
p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells
Yasamin Dabiri et al.
FRONTIERS IN ONCOLOGY (2019)
Triggering mitosis
Adrijana Crncec et al.
FEBS LETTERS (2019)
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions
Tina Fonnes et al.
GYNECOLOGIC ONCOLOGY (2018)
Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma
Jutta Huvila et al.
GYNECOLOGIC ONCOLOGY (2018)
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
Chuan Xing Wu et al.
THERANOSTICS (2018)
CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
Dinoop Ravindran Menon et al.
CANCER RESEARCH (2018)
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
Julien Bollard et al.
GUT (2017)
Cell cycle inhibitors boost tumour immunogenicity
Kirsty Minton
NATURE REVIEWS DRUG DISCOVERY (2017)
Discovery of human-like L-asparaginases with potential clinical use by directed evolution
Coraline Rigouin et al.
SCIENTIFIC REPORTS (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Recent developments in L-asparaginase discovery and its potential as anticancer agent
Abhinav Shrivastava et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Targeting the cell cycle: A new approach to cancer therapy
GK Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A novel asparaginase-like protein is a sperm autoantigen in rats
LA Bush et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2002)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Share Paper
